Abstract

There is a substantive clinical literature on classical hallucinogens, most commonly lysergic acid diethylamide (LSD) for the treatment of alcohol use disorder. However, there has been no published research on the effect of LSD on alcohol consumption in animals. This study evaluated the effect of LSD in mice using a two-bottle choice alcohol drinking paradigm. Adult male C57BL/6J mice were exposed to ethanol to develop preference and divided into three groups of equal ethanol consumption, and then treated with single intraperitoneal injection of saline or 25 or 50 μg/kg LSD and offered water and 20% ethanol. The respective LSD-treated groups were compared to the control group utilizing a multilevel model for repeated measures. In mice treated with 50 μg/kg LSD ethanol consumption was reduced relative to controls (p = 0.0035), as was ethanol preference (p = 0.0024), with a group mean reduction of ethanol consumption of 17.9% sustained over an interval of 46 days following LSD administration. No significant effects on ethanol consumption or preference were observed in mice treated with 25 μg/kg LSD. Neither total fluid intake nor locomotor activity in the LSD-treated groups differed significantly from controls. These results suggest that classical hallucinogens in the animal model merit further study as a potential approach to the identification of targets for drug discovery and investigation of the neurobiology of addiction.

Highlights

  • Alcohol-related disorders accounted for approximately 88,000 deaths annually and one in ten deaths in working age adults in the US from 2006 to 2010 (Stahre et al, 2014), and are estimated to cause 5.9% of deaths worldwide (World Health Organization, 2014)

  • For the group treated with 25 μg/kg, equivalence was reached at day 23; for the group treated with 50 μg/kg lysergic acid diethylamide (LSD) it had not been reached at the time the study was terminated on day 46

  • Ethanol preference, defined as ethanol consumption/total fluid intake, was decreased relative to controls in the 50 μg/kg LSD group (F = 13.32, df = 15, p = 0.0024; Figure 1D), with no difference from control for the group treated with 25 μg/kg LSD (F = 0.53, df = 17, p = 0.475; Figure 1C)

Read more

Summary

Introduction

Alcohol-related disorders accounted for approximately 88,000 deaths annually and one in ten deaths in working age adults in the US from 2006 to 2010 (Stahre et al, 2014), and are estimated to cause 5.9% of deaths worldwide (World Health Organization, 2014). The literature on LSD for the treatment of AUD extends back to the 1950s, and a meta-analysis that included 6 randomized controlled trials (RCTs) involving a total of 536 subjects found that treatment with a single dose of LSD significantly reduced alcohol misuse for up to three months (Krebs and Johansen, 2012). This meta-analysis retrieved an additional 23 non-RCT open-label studies, case reports, or studies that did not otherwise meet inclusion criteria, indicating the considerable extent of the historical interest in clinical research on LSD for the treatment of AUD

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call